Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: €0.03 M
• Last 3 months FTD volume: €1.89 M
• Last 12 months FTD volume: €4.32 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	€33.81 M	€0.17 B	🇺🇸 USA
SIGA Technologies SIGA	€0.36 M	€1.53 M	🇺🇸 USA
GlaxoSmithKline GSK	€72.01 M	€0.40 B	🇬🇧 UK
Celldex Therapeutics CLDX	€7.65 M	€11.96 M	🇺🇸 USA
Pfizer PFE	€24.63 M	€0.10 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	€1.84 M	€36.3 M	🇮🇱 Israel
Soligenix SNGX	€5.86 M	€13.89 M	🇺🇸 USA